NDC 42283-020-00
API & Excipient Details

marketed by Laboratorios Genesse SL under NDC Code 42283-020-00

NDC Code(s) : 42283-020-00
Packager : Laboratorios Genesse SL

Category : HUMAN PRESCRIPTION DRUG LABEL

DEA Schedule : none

Marketing Status : New Drug Application

INGREDIENTS AND APPEARANCE

Lactovit DEODORANT AND ANTIPERSPIRANT INVISIBLE ANTISTAINALUMINUM CHLOROHYDRATE LIQUID

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NDC:42283-020
Route of Administration	TOPICAL	DEA Schedule

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
ALUMINUM SESQUICHLOROHYDRATE(UNII: UCN889409V) (ALUMINUM SESQUICHLOROHYDRATE - UNII:UCN889409V)	ALUMINUM SESQUICHLOROHYDRATE	1 mg
ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY(UNII: P9D3YP29MY) (ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY - UNII:P9D3YP29MY)	ALUMINUM ZIRCONIUM OCTACHLOROHYDREX GLY	8 mg

Ingredient Name	Strength
Inactive Ingredients
VINYLPYRROLIDONE/EICOSENE COPOLYMER(UNII: 035MV9S1C3)	0.3 mL in 1 1
GLYCINE(UNII: TE7660XO1C)	0.0002 mL in 1 1
SODIUM ALGINATE(UNII: C269C4G2ZQ)	0.01224 mL in 1 1
WATER(UNII: 059QF0KO0R)	0.00001 mL in 1 1
STEARETH-2(UNII: V56DFE46J5)	3 mL in 1 1
PPG-15 STEARYL ETHER(UNII: 1II18XLS1L)	2 mL in 1 1
STEARETH-21(UNII: 53J3F32P58)	1.5 mL in 1 1
BUTYLENE GLYCOL(UNII: 3XUS85K0RA)	0.8 mL in 1 1
SODIUM LACTATE(UNII: TU7HW0W0QT)	0.0001 mL in 1 1
CASEIN(UNII: 48268V50D5)	0.019 mL in 1 1
.ALPHA.-TOCOPHEROL ACETATE(UNII: 9E8X80D2L0)	0.2 mL in 1 1
ALLANTOIN(UNII: 344S277G0Z)	0.1 mL in 1 1
CHITOSAN PCA(UNII: 6X7Y81JM3P)	0.05784 mL in 1 1
CYCLOMETHICONE 5(UNII: 0THT5PCI0R)	0.5 mL in 1 1
PERFLUNAFENE(UNII: 54A06VV62N)	1.36 mL in 1 1
EDETATE DISODIUM(UNII: 7FLD91C86K)	0.2 mL in 1 1
PHENOXYETHANOL(UNII: HIE492ZZ3T)	0.0004 mL in 1 1

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:42283-020-00	50 in 1 BOTTLE Type 0: Not a Combination Product	19/11/2016

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC monograph final	part350	11/19/2016

PRINCIPAL DISPLAY PANEL